ProKidney Corp. (PROK)

ProKidney Statistics

Total Valuation

ProKidney has a market cap or net worth of $266.35 million. The enterprise value is -$88.70 million.

Market Cap	266.35M
Enterprise Value	-88.70M

Important Dates

The last earnings date was Monday, March 17, 2025, before market open.

Earnings Date	Mar 17, 2025
Ex-Dividend Date	n/a

Share Statistics

ProKidney has 292.70 million shares outstanding. The number of shares has increased by 58.66% in one year.

Current Share Class	129.54M
Shares Outstanding	292.70M
Shares Change (YoY)	+58.66%
Shares Change (QoQ)	+1.61%
Owned by Insiders (%)	21.85%
Owned by Institutions (%)	31.92%
Float	80.44M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3,504.67
Forward PS	n/a
PB Ratio	0.66
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.93, with a Debt / Equity ratio of 0.01.

Current Ratio	10.93
Quick Ratio	9.96
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-19,816.89

Financial Efficiency

Return on equity (ROE) is -41.20% and return on invested capital (ROIC) is -27.85%.

Return on Equity (ROE)	-41.20%
Return on Assets (ROA)	-25.87%
Return on Invested Capital (ROIC)	-27.85%
Return on Capital Employed (ROCE)	-44.05%
Revenue Per Employee	$373
Profits Per Employee	-$299,931
Employee Count	204
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	-598,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -42.04% in the last 52 weeks. The beta is 1.48, so ProKidney's price volatility has been higher than the market average.

Beta (5Y)	1.48
52-Week Price Change	-42.04%
50-Day Moving Average	1.34
200-Day Moving Average	1.88
Relative Strength Index (RSI)	32.37
Average Volume (20 Days)	559,645

Short Selling Information

The latest short interest is 11.82 million, so 4.04% of the outstanding shares have been sold short.

Short Interest	11.82M
Short Previous Month	11.93M
Short % of Shares Out	4.04%
Short % of Float	14.69%
Short Ratio (days to cover)	21.39

Income Statement

In the last 12 months, ProKidney had revenue of $76,000 and -$61.19 million in losses. Loss per share was -$0.62.

Revenue	76,000
Gross Profit	76,000
Operating Income	-178.35M
Pretax Income	-34.94M
Net Income	-61.19M
EBITDA	-172.92M
EBIT	-178.35M
Loss Per Share	-$0.62

Balance Sheet

The company has $358.29 million in cash and $3.24 million in debt, giving a net cash position of $355.06 million or $1.21 per share.

Cash & Cash Equivalents	358.29M
Total Debt	3.24M
Net Cash	355.06M
Net Cash Per Share	$1.21
Equity (Book Value)	401.64M
Book Value Per Share	-7.77
Working Capital	359.67M

Cash Flow

In the last 12 months, operating cash flow was -$126.35 million and capital expenditures -$29.51 million, giving a free cash flow of -$155.86 million.

Operating Cash Flow	-126.35M
Capital Expenditures	-29.51M
Free Cash Flow	-155.86M
FCF Per Share	-$0.53

Margins

Gross Margin	100.00%
Operating Margin	-234,673.68%
Pretax Margin	-215,701.32%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ProKidney does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-58.66%
Shareholder Yield	n/a
Earnings Yield	-22.97%
FCF Yield	-58.52%

Analyst Forecast

The average price target for ProKidney is $5.00, which is 449.45% higher than the current price. The consensus rating is "Buy".

Price Target	$5.00
Price Target Difference	449.45%
Analyst Consensus	Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	276.60%
EPS Growth Forecast (5Y)	-18.52%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ProKidney has an Altman Z-Score of -1.1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.1
Piotroski F-Score	n/a